FeedsNMDP Board of Directors
Officers:
Rebecca A. Lewis, Esquire, Chair-elect
Susan L. Rossmann, M.D., Ph.D., Vice Chair
Rebecca McCullough, Secretary
Members:
Edward L. Snyder, M.D., Chair
Dr. Edward L. Snyder is the director of the Blood Bank/Apheresis Service at the Yale-New Haven Hospital in New Haven, Conn., and a professor of laboratory medicine at Yale University Medical School. He joined the NMDP board of directors in January 1999 and is a past chair of the NMDP's Strategic Planning and Nominating committees. He is also a past chair of the AABB, formerly known as the American Association of Blood Banks. Snyder is on the editorial board of Transfusion and Blood journals and has published more than 225 articles in the field of transfusion medicine. Snyder graduated from New York Medical College.
Rebecca A. Lewis, Esquire, Chair-elect
Rebecca A. Lewis received an unrelated donor transplant through the NMDP in 1997. She serves on the NMDP's Executive Committee. Lewis is chair and a member of the Patient Services Committee, and a past chair of the Board Development and Compensation committees. Lewis is chief bar counsel for the Wyoming State Bar Association and a former adjunct professor of law at the University of Wyoming College of Law. Lewis has served on a number of boards, including the boards of the Ivinson Memorial Hospital Foundation and the Wyoming State Bar Foundation. Lewis earned a Bachelor of Arts from Stanford University and a Juris Doctor from Duke University.
Susan L. Rossmann, M.D., Ph.D., Vice Chair
Dr. Susan L. Rossmann is a past president of the NMDP Council, representing donor centers. She is the chief medical officer of the Gulf Coast Regional Blood Center in Houston; an adjunct associate professor at Baylor College of Medicine; and on the pathology staff at The Methodist Hospital in Houston. Rossmann serves as chair of the Scientific, Medical and Technical Committee of America's Blood Centers. She is a member of the Donor History Questionnaire Task Force and several ad hoc committees of the AABB, an international association of blood banks. Rossmann is also a delegate from the Harris County Medical Society to the Texas Medical Association (TMA) and a member of the Blood and Tissue Usage Committee of the TMA. Rossmann received her Bachelor of Arts from Mount Holyoke College, her Ph.D. in biological anthropology from the University of Michigan and Doctor of Medicine from Baylor College of Medicine.
Rebecca McCullough, Secretary
As director of the Marrow Program at Gulf Coast Regional Blood Center in Houston, Texas, McCullough oversees the education and recruitment of donors, with a primary focus on minority donors. McCullough developed the Gulf Coast Marrow Donor Program in 1991, and her efforts include expanding an initial $220K grant to a program supported by ten full-time staff. She also presides over a community-based volunteer executive advisory board, volunteer committees, and fundraising as well as conducts public and individual presentations. McCullough served previously on the NMDP Donor Recruitment and Minority Affairs committees and as an NMDP Council officer. McCullough received her bachelor's degree from Texas A&M University.
Deborah A. Abroal
Deborah A. Abroal is an event planner with Barclays Capital, New York, and was a recipient of an allogeneic stem cell transplant in May 2007. This journey through illness, treatment and healing gives her insight and empathy for those in need of the NMDP's services. Ms. Abroal received her Bachelor of Arts in English Literature and philosophy from New York University in May 2000, and previously was an assistant teacher at The Packer Collegiate Institute in Brooklyn, New York.
Daniel D. Arndt
Daniel D. Arndt is a past chair of the NMDP Audit Committee. Under his leadership, NMDP staff and the committee compiled and completed necessary audits, created and implemented an Audit Committee Charter, created the Whistleblower Policy, and have begun a reporting process to comply with the Sarbanes-Oxley Act. As staff vice president and General Auditor at 3M for more than a decade, Arndt was directly involved in addressing changes to comply with corporate governance requirements throughout the world. He also participated in initiatives that helped 3M be successful in the ever-changing competitive and regulatory environments. He has served on various boards, including the Institute of Internal Auditors, Twin Cities Chapter; Greater Minneapolis Chamber of Commerce; and International School of Brussels, Belgium. Arndt received a Bachelor of Science in business administration from Northwestern University and earned his Master of Business Administration from the University of Chicago.
Nelson Chao, M.D.
Dr. Nelson Chao is currently professor of medicine and immunology, chief of the Division of Cellular Therapy and Bone Marrow Transplant and co-director of the Stem Cell Laboratory at Duke University. He joined the NMDP board of directors in January 2010. He is also chair of the Radiation Injury Treatment Network and the BSC Gateway for Cancer Research. Chao is on the editorial board of Blood, Hematologist and Experimental Hematology as well as associate editor of both Biology of Blood and Marrow Transplantation and Graft. Chao received his bachelor's degree cum laude from Harvard University and earned his medical degree from Yale University. He completed his residency at the Stanford University Medical Center. He was an American Cancer Society Fellow at Stanford University and a fellow in oncology at Stanford University Medical Center in Stanford, Calif.
Colleen R. Chapleau, B.B.A., CHTC
Colleen R. Chapleau began her career in marrow transplantation in 1985 by recruiting volunteers to be donors and coordinating donor searches for patients in need of an unrelated transplant. Today she is the associate director of the Iowa Marrow Donor Program and the Blood & Marrow Transplantation Program at the University of Iowa Hospitals & Clinics. She has been affiliated with the NMDP since its beginning and has served on various committees over the years. She is a business graduate of the University of Wisconsin and is currently working on her executive Master of Business Administration at the Henry B. Tippie College of Business in the University of Iowa.
Rex L. Crawley, Ph.D.
Rex L. Crawley is a cancer survivor and bone marrow transplant recipient. Crawley is president of the Jefferson County, Penn. unit of the American Cancer Society and is department head and an associate professor of communications at Robert Morris University in Pittsburgh. His research interests center on the experiences of African American men, and he has published several articles on Black Masculinity. He is currently working on a book focusing on intercultural/international communications. Crawley earned a Master of Arts in public administration and a Ph.D. in intercultural communications from Ohio University.
Sergio A. Giralt, M.D.
Dr. Sergio A. Giralt is deputy chair of the Department of Stem Cell Transplantation and Cellular Therapy of the University of Texas, M.D. Anderson Cancer Center, where he is also a professor of medicine. Dr. Giralt currently serves as the chair of the Executive Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). The work of Giralt and his colleagues has been instrumental in developing non-myeloablative transplantation, resulting in bone marrow transplants now being available to a much broader group of patients. He has expertise in international collaboration on clinical and research issues and is chair of the Toxicity Committee for the Bone Marrow Transplant Clinical Trials Network (BMT CTN), which is responsible for developing guidelines for diagnosing and monitoring transplant-related complications. Along with a variety of honors and awards in hematology and oncology and more than 50 articles in peer-reviewed journals, Giralt brings an in-depth understanding of the many issues faced by patients, their families and their health care providers. He earned his Doctor of Medicine from Universidad Central de Venezuela. His postgraduate research and medical training was done at Harvard Medical, Good Samaritan Hospital, and M.D. Anderson Cancer Center.
Gary A. Goldstein
Gary A. Goldstein is a marrow donor and a recognized health care finance expert in the field of blood and marrow transplantation. With knowledge gained in more than 13 years of experience in the Stanford bone marrow transplant program, Goldstein has provided consulting services to biopharmaceutical companies, medical device corporations and health care providers. He has been a featured speaker at national and international transplant conferences and has presented talks to cancer support groups. In his position as a financial specialist, he is a patient advocate for getting treatments approved and helping patients find sources of funding. He received his Bachelor of Arts in business economics from the University of California, Santa Barbara.
Michael Jhin, M.B.A.
Michael Jhin is chairman and CEO of Harbor Sky and CEO Emeritus at St. Luke's Episcopal Health System in Houston, Texas. He joined the NMDP board of directors in January 2010. Michael Jhin's career spans 30 years, all of it in American teaching hospitals and primarily as a CEO. He has devoted his entire career to recapturing the “care” and “health” in American healthcare. While Jhin was CEO, St. Luke's Episcopal Health System was recognized by Fortune as one of the nation's 100 best companies to work for and was consistently ranked by U.S. News and World Report as one of the top 10 cardiovascular centers in the United States. Jhin has served on the corporate boards of EGL Inc. and Triad Hospitals. Jhin received his bachelor's degree in mechanical engineering at Rensselaer Polytechnic Institute and his M.B.A. from Boston University while fulfilling his health care administration concentration at the Harvard University School of Public Health.
Chatchada Karanes, M.D.
Dr. Chatchada Karanes is the director of the Cord Blood Transplant Program and the Division of Hematology and Hemotopoietic Cell Transplantation at City of Hope National Medical Center. Dr. Karanes has a long history with NMDP. She participated on the Patient Services Committee and from 2000-2005 served as medical director. She joined the NMDP board of directors in January 2010. She was previously on the board of directors for the Michigan Hematology-Oncology Society and the Children's Leukemia Foundation of Michigan. Karanes taught at Wayne State University School of Medicine in the Department of Internal Medicine Division of Hematology and Oncology for 22 years. Karanes graduated from the Ramathibodi Medical School in Bangkok, Thailand. She completed her residency in Internal Medicine at St Francis Hospital in Evanston, Ill. and had a clinical fellowship in hematology oncology at Washington University School of Medicine in St. Louis, Mo.
Miriam A. Markowitz
Miriam A. Markowitz is the corporate vice president, strategic planning and business development at the Children's National Medical Center in Washington, D.C. Previous roles at CNMC include director, strategic planning and business development and center director, Center for Cancer and Blood Disorders. She brings to the board an expertise in strategic planning, negotiation and business development. Ms. Markowitz was recently appointed to the Board of Medicine, District of Columbia and volunteers with Mentors, Inc., a non-profit organization dedicated to providing mentors to high school students in the District of Columbia. Markowitz received a Master of Science in health policy and management from Harvard University, and has a B.A. in economics from Brandeis University, with an emphasis in women's studies and health economics.
Bernadette Murray-Fertel
Bernadette Murray-Fertel was diagnosed with an aggressive form of acute myelogenous leukemia in May 2005 and matched with a donor through NMDP, which she credits as saving her life. Murray-Fertel is founder and executive director of DonorRevolution.org, whose sole mission is "to create Awareness, Empathy and Action for the cause of saving more lives through bone marrow, stem cell and cord blood transplants." She is a senior marketing executive with more than 25 years of experience in the advertising and publishing sectors. She is also an active board member of other philanthropic initiatives, including the New York Stem Cell Foundations Leadership Council and Alpha Workshops, an organization dedicated to retraining people living with HIV in the decorative arts.
Eneida Nemecek M.D.
Dr. Eneida Nemecek is associate professor of Pediatrics/Hematology-Oncology at Doernbecher Children's Hospital in Portland, Ore. She joined the NMDP board of directors in January 2010 and is serving as scientific director. She also serves as medical monitor of CIBMTR and pediatric scientific liaison for NHLBI/Bone Marrow Transplant Clinical Trials Network. Nemecek is dedicated to researching bone marrow transplantation focusing on late effects of bone marrow transplantation, cord blood banking for public use and procurement of marrow donors from ethnically diverse backgrounds. Nemecek received her medical degree from the University of Puerto Rico School of Medicine and completed her residency at Rainbow Babies and Children's Hospital in Cleveland, Ohio. She was also a fellow in the Division of Pediatric Hematology and Oncology at Fred Hutchinson Cancer Research Center in Seattle, Wash.
Esperanza B. Papadopoulos, M.D.
Dr. Esperanza B. Papadopoulos is an associate attending physician on the Allogeneic Bone Marrow Transplantation Service at Memorial Sloan-Kettering Cancer Center in New York City. Papadopoulos' clinical and research work focuses on improving the effectiveness and safety of allogeneic transplants for patients with hematologic malignancies, with particular emphasis on the management of post-transplant complications. Papadopoulos has served as a member and chair of the NMDP Membership and Process Improvement Committee and the Donor and Patient Safety Monitoring Committee, as well as a member of the Standards Committee. She received her medical degree from the New York University School of Medicine.
Stelios Papadopoulos, Ph.D.
Stelios Papadopoulos is co-founder and chairman of the board of directors of Exelixis, Inc., a biotechnology company that discovers and develops new treatments for cancer and metabolic diseases. He is also co-founder and a board member of Anadys Pharmaceuticals, Inc. and Cellzome, Inc., vice chair of the board of directors for BG Medicine, Inc. and a board member of Neuronyx, Inc. He is also a member of the Scientific Advisory Board of Symphony Capital, LLC. While forming new companies, Papadopoulos also spent more than two decades on Wall Street as a biotechnology analyst and an investment banker. As an investment banker, he was the advisor of record in numerous mergers and acquisitions and assisted biotechnology companies in raising several billion dollars for research and development. Papadopoulos is a member of the Board of Visitors of Duke University Medical Center. He is also co-founder and chairman of Fondation Santé, a foundation that provides scholarships to students from Greece and assists young scientists from Greece and other Balkan countries to secure traineeships in biotechnology companies in the U.S. and Europe. Papadopoulos is an adjunct associate professor of cell biology at New York University Medical Center. He earned a Master of Science in physics, a Ph.D. in biophysics and a Master of Business Administration in finance, all from New York University.
Thomas Price, M.D.
Dr. Thomas H. Price is executive vice president and medical director for Puget Sound Blood Center and professor of medicine at the University of Washington, both located in Seattle. An active and dedicated NMDP volunteer, Price has served on a number of task forces and as the medical director of the Puget Sound Blood Center, an NMDP donor center, since 1990. He is a past chair of the Nominating, Membership and Process Improvement, and Donor and Patient Safety Monitoring committees and has served as a member of the Standards Committee. Price received his Bachelor of Science in chemistry from the University of Michigan and his Doctor of Medicine from The Johns Hopkins University.
Zbigniew (Ziggy) Szczepiorkowski, Ph.D., M.D.
Dr. Zbigniew Szczepiorkowski is associate professor of pathology and medicine; medical director, Transfusion Medical Service; and director, Cellular Therapy Center at Dartmouth Hitchcock Medical Center. He joined the NMDP board of directors in January 2010 and is chair of the NMDP Standards Committee. He serves as president of the board of directors for the American Society for Apheresis and is a member of the Executive and Advisory Committee with CIBMTR. He also served as co-chair of the State of the Science in Transfusion Medicine for NHLBI. He is associate editor of Journal of Clinical Apheresis, and is on the editorial board for Journal of Translational Medicine and Journal of Transfusion Medicine. Szczepiorkowski recieved his medical degree magna cum laude at Warsaw Medical University and his Ph.D. in medicine at the Postgraduate Center of Medical Education in Warsaw. He was a clinical and research fellow at Harvard Medical School in Boston, Mass.
Dennis Todd, M.S., M.B.A., Ph.D.
Dr. Dennis Todd is president and CEO of Bergen Community Regional Blood Center. He has served on the NMDP Cord Blood Committee since 2006, and joined the NMDP board of directors in January 2010. Todd is legislative committee chair for Americas Blood Centers. He is a former associate professor with the School of Graduate Medical Education at Seton Hall University in South Orange, N.J. Todd has been the recipient of many grants for cancer research, particularly in the field of breast cancer, and has published numerous papers and abstracts. Todd received his masters and Ph.D. in Analytical Chemistry from Lehigh University, in Bethlehem, Pa. He received his M.B.A. from Marist College in Poughkeepsie, N.Y.
John R. Wingard, M.D.
Dr. John R. Wingard is the Price Eminent Scholar and professor of medicine and pediatrics at the University of Florida. He is director of the Bone Marrow Transplant Program at the University of Florida, deputy director of the University of Florida Shands Cancer Center and medical director for the LifeCord Cord Blood Program in Florida. His transplantation research includes authoring three books, 38 book chapters and nearly 300 articles in professional journals. He is on the editorial board of three journals and is the editor of the periodical: Blood and Marrow Transplant Reviews. As a seasoned leader with extensive knowledge in blood and marrow transplantation, Wingard is a member and chair of several national committees. For more than a decade he has been a National Institute of Health reviewer for ad hoc site visits and has been a consultant for the Social Security Administration, the Center for Disease Control and Prevention and the Department of Defense. Wingard earned his Bachelor of Arts at Yale University and his Doctor of Medicine from The Johns Hopkins University.
Ann E. Woolfrey, M.D.
Dr. Ann Woolfrey is associate professor in pediatrics at the University of Washington and associate member in the Pediatric Bone Marrow Transplant and Immunogenetics Program at Fred Hutchinson Cancer Research Center. She is also the director of the Unrelated Donor Marrow Program for Seattle Cancer Care Alliance. Woolfrey joined the NMDP board of directors in January 2010. She is also on the advisory committee for the Radiation Injury Transplant Network and co-chair of the chronic leukemia committee for CIBMTR. She received the Minnesota Medical Foundation Undergraduate Research Award, American Cancer Society's Young Investigator Honored Presentation Award and was accepted into the Honors Program at Cambridge University in Cambridge, England. She received her medical degree at the University of Minnesota in Minneapolis, Minn. She was a fellow in hematology and oncology at Children's Hospital and Medical Center at Fred Hutchinson Cancer Research Center in Seattle, Wash.
